CRANAD-28
CRANAD-28 is a small molecule imaging probe designed for Alzheimer's disease research. It crosses the blood-brain barrier and enables two-photon in vivo visualization of amyloid-beta plaques and cerebral amyloid angiopathy in model systems, facilitating longitudinal studies of amyloid pathology.
Product Specifications
CAS Number
1623747-97-6
Product Name Alternative
Inhibitor, inhibit, beta plaques, CRANAD 28, CRANAD28, CRANAD-28
Purity
98.96% (May vary between batches)
Solubility
DMSO:4.85 mg/mL (10.01 mM)
Smiles
Cc1c (\C=C\C2=CC (\C=C\c3cnn (c3C) -c3ccccc3) =[O+][B-] (F) (F) O2) cnn1-c1ccccc1
Molecular Formula
C27H23BF2N4O2
Molecular Weight
484.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15158069 1 Vial
Lentiviral human TIGD1 shRNA (UAS) - Lentiviral human TIGD1 shRNA (UAS) (25)
Sign In for Pricing
View Details 
